Heron Therapeutics
HRTX
HRTX
171 hedge funds and large institutions have $192M invested in Heron Therapeutics in 2025 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 56 increasing their positions, 52 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
2.89% less ownership
Funds ownership: 86.17% → 83.28% (-2.9%)
29% less capital invested
Capital invested by funds: $272M → $192M (-$79.8M)
98% less call options, than puts
Call options by funds: $44K | Put options by funds: $2.68M
Holders
171
Holding in Top 10
3
Calls
$44K
Puts
$2.68M
Top Buyers
| 1 | +$11.2M | |
| 2 | +$5.36M | |
| 3 | +$3.05M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$3.01M |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$3.01M |
Top Sellers
| 1 | -$6.23M | |
| 2 | -$3.55M | |
| 3 | -$2M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.7M |
| 5 |
JFG
Jefferies Financial Group
New York
|
-$1.38M |
